These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 26373896

  • 21. Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.
    Kamar N, Cassuto E, Piotti G, Govoni M, Ciurlia G, Geraci S, Poli G, Nicolini G, Mariat C, Essig M, Malvezzi P, Le Meur Y, Garrigue V, Del Bello A, Rostaing L.
    Adv Ther; 2019 Feb; 36(2):462-477. PubMed ID: 30552587
    [Abstract] [Full Text] [Related]

  • 22. Conversion from twice-daily to once-daily extended-release tacrolimus in renal transplant recipients: 2-year results and review of the literature.
    Tran D, Vallée M, Collette S, Senécal L, Lafrance JP, Dandavino R, Boucher A.
    Exp Clin Transplant; 2014 Aug; 12(4):323-7. PubMed ID: 24844288
    [Abstract] [Full Text] [Related]

  • 23. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen.
    Alloway R, Steinberg S, Khalil K, Gourishankar S, Miller J, Norman D, Hariharan S, Pirsch J, Matas A, Zaltzman J, Wisemandle K, Fitzsimmons W, First MR.
    Transplant Proc; 2005 Mar; 37(2):867-70. PubMed ID: 15848559
    [Abstract] [Full Text] [Related]

  • 24. Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study.
    Krämer BK, Charpentier B, Bäckman L, Silva HT, Mondragon-Ramirez G, Cassuto-Viguier E, Mourad G, Sola R, Rigotti P, Mirete JO, Tacrolimus Prolonged Release Renal Study Group.
    Am J Transplant; 2010 Dec; 10(12):2632-43. PubMed ID: 20840480
    [Abstract] [Full Text] [Related]

  • 25. Meltdose Tacrolimus Pharmacokinetics.
    Baraldo M.
    Transplant Proc; 2016 Mar; 48(2):420-3. PubMed ID: 27109969
    [Abstract] [Full Text] [Related]

  • 26. Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf.
    Woillard JB, de Winter BC, Kamar N, Marquet P, Rostaing L, Rousseau A.
    Br J Clin Pharmacol; 2011 Mar; 71(3):391-402. PubMed ID: 21284698
    [Abstract] [Full Text] [Related]

  • 27. Pilot Study Comparing the Efficacy, Safety, Convertibility, and Tacrolimus Trough Levels of Twice-Daily Tacrolimus (Prograf) to Once-Daily Tacrolimus (Advagraf) Among Standard-Risk Kidney Transplant Patients at the National Kidney and Transplant Institute.
    Danguilan RA, Lamban A, Pamugas GEP.
    Transplant Proc; 2019 Oct; 51(8):2615-2619. PubMed ID: 31563241
    [Abstract] [Full Text] [Related]

  • 28. De novo kidney transplant recipients need higher doses of Advagraf compared with Prograf to get therapeutic levels.
    Crespo M, Mir M, Marin M, Hurtado S, Estadella C, Gurí X, Rap O, Moral R, Puig JM, Lloveras J.
    Transplant Proc; 2009 Oct; 41(6):2115-7. PubMed ID: 19715848
    [Abstract] [Full Text] [Related]

  • 29. LCPT once-daily extended-release tacrolimus tablets versus twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroups.
    Bunnapradist S, Rostaing L, Alloway RR, West-Thielke P, Denny J, Mulgaonkar S, Budde K.
    Transpl Int; 2016 May; 29(5):603-11. PubMed ID: 26953629
    [Abstract] [Full Text] [Related]

  • 30. First clinical experience with the new once-daily formulation of tacrolimus.
    First MR.
    Ther Drug Monit; 2008 Apr; 30(2):159-66. PubMed ID: 18367975
    [Abstract] [Full Text] [Related]

  • 31. Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation.
    Kolonko A, Chudek J, Wiecek A.
    Transplant Proc; 2011 Oct; 43(8):2950-3. PubMed ID: 21996198
    [Abstract] [Full Text] [Related]

  • 32. Significant reduction of Tacrolimus trough level after conversion from twice daily Prograf to once daily Advagraf in Chinese renal transplant recipients with or without concomitant diltiazem treatment.
    Ma MK, Kwan LP, Mok MM, Yap DY, Tang CS, Chan TM.
    Ren Fail; 2013 Aug; 35(7):942-5. PubMed ID: 23815459
    [Abstract] [Full Text] [Related]

  • 33. Extended-release tacrolimus: a review of its use in de novo kidney transplantation.
    McCormack PL.
    Drugs; 2014 Nov; 74(17):2053-64. PubMed ID: 25352392
    [Abstract] [Full Text] [Related]

  • 34. Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients.
    Alloway R, Steinberg S, Khalil K, Gourishankar S, Miller J, Norman D, Hariharan S, Pirsch J, Matas A, Zaltzman J, Wisemandle K, Fitzsimmons W, First MR.
    Transplantation; 2007 Jun 27; 83(12):1648-51. PubMed ID: 17589351
    [Abstract] [Full Text] [Related]

  • 35. Population pharmacokinetics of immediate- and prolonged-release tacrolimus formulations in liver, kidney and heart transplant recipients.
    Lu Z, Bonate P, Keirns J.
    Br J Clin Pharmacol; 2019 Aug 27; 85(8):1692-1703. PubMed ID: 30950096
    [Abstract] [Full Text] [Related]

  • 36. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
    Song GW, Lee SG, Hwang S, Kim KH, Kim WJ, Sin MH, Yoon YI, Tak EY.
    Exp Clin Transplant; 2016 Aug 27; 14(4):412-8. PubMed ID: 26976646
    [Abstract] [Full Text] [Related]

  • 37. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
    Considine A, Tredger JM, Heneghan M, Agarwal K, Samyn M, Heaton ND, O'Grady JG, Aluvihare VR.
    Liver Transpl; 2015 Jan 27; 21(1):29-37. PubMed ID: 25312292
    [Abstract] [Full Text] [Related]

  • 38. Once-daily prolonged-release tacrolimus formulations for kidney transplantation: what the nephrologist needs to know.
    Piotti G, Cremaschi E, Maggiore U.
    J Nephrol; 2017 Feb 27; 30(1):53-61. PubMed ID: 27206763
    [Abstract] [Full Text] [Related]

  • 39. Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation.
    Calia R, Lai C, Aceto P, Luciani M, Romagnoli J, Lai S, Gargiulo A, Citterio F.
    Transplant Proc; 2011 May 27; 43(4):1020-3. PubMed ID: 21620041
    [Abstract] [Full Text] [Related]

  • 40. Renal function and safety in stable kidney transplant recipients converted from immediate-release to prolonged-release tacrolimus.
    Lauzurica R, Morales JM, van Hooff J, Study Investigators.
    Transpl Int; 2012 Jan 27; 25(1):48-55. PubMed ID: 21992068
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.